Seres Therapeutics
MCRB
MCRB
91 hedge funds and large institutions have $198M invested in Seres Therapeutics in 2019 Q2 according to their latest regulatory filings, with 24 funds opening new positions, 33 increasing their positions, 14 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
0.43% more ownership
Funds ownership: 4.11% → 4.54% (+0.43%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
15% less capital invested
Capital invested by funds: $232M → $198M (-$33.8M)
Holders
91
Holding in Top 10
1
Calls
$1.82M
Puts
$284K
Top Buyers
| 1 | +$28.6M | |
| 2 | +$13M | |
| 3 | +$13M | |
| 4 |
PA
Perceptive Advisors
New York
|
+$8.05M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$7.34M |
Top Sellers
| 1 | -$417K | |
| 2 | -$400K | |
| 3 | -$318K | |
| 4 |
Swiss National Bank
Zurich,
Switzerland
|
-$248K |
| 5 |
Russell Investments Group
London,
United Kingdom
|
-$169K |